Cartesian Therapeutics, Inc. Annual Return On Assets in % from 2017 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Cartesian Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from 2017 to 2023.
  • Cartesian Therapeutics, Inc. Return On Assets for the quarter ending June 30, 2024 was -84.7 %, a 286% decline year-over-year.
  • Cartesian Therapeutics, Inc. annual Return On Assets for 2023 was -124 %, a 696% decline from 2022.
  • Cartesian Therapeutics, Inc. annual Return On Assets for 2022 was 20.9 %.
  • Cartesian Therapeutics, Inc. annual Return On Assets for 2021 was -15 %, a 72.2% increase from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -124 -145 -696% Jan 1, 2023 Dec 31, 2023
2022 20.9 +35.9 Jan 1, 2022 Dec 31, 2022
2021 -15 +39 +72.2% Jan 1, 2021 Dec 31, 2021
2020 -54 +35.1 +39.4% Jan 1, 2020 Dec 31, 2020
2019 -89.1 +8.37 +8.59% Jan 1, 2019 Dec 31, 2019
2018 -97.5 -32.4 -49.8% Jan 1, 2018 Dec 31, 2018
2017 -65 Jan 1, 2017 Dec 31, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.